2012internationalconference-medical

 

Breakout Title:
Designing for Mayo Clinic and the Future of Health Care
MEREDITH DeZUTTER

The Mayo Clinic is currently engaged in a multi-year initiative to redesign their outpatient practice to continue to be relevant and financially sustainable into the future. To execute this initiative, we have designed a process that builds on traditional design methodologies for framing, identifying and conceptualizing new ideas, ultimately creating a new approach that allows us to better understand the complexity inherent in large systems. With this process, we are attempting to define a new offering by simultaneously looking at the existing clinic as well as the disruptive landscape drivers that will impact Mayo in the future. This presentation will highlight our approach to redesigning the outpatient practice, cite some of our specific research and provide a glimpse of some initial plans we have for the outpatient practice of the future.

Breakout Title:
Driving Medical Device Success with Consumer Product Insights
PAUL LEONARD and LINDA WAGNER

In this session, we will explore the rapidly changing medical device market. Companies who deliver great user experiences that harmonize functionality, usability and desirability will capture market share as they capture their customers’ hearts. Two forces are driving medical devices to become more like consumer products: patient use and physician expectations. Today, more and more medical devices are being used directly by patients themselves, allowing them to participate directly in their own care. Consumer thinking can benefit the makers of nearly every kind of medical device. Whether the end-user is a physician, nurse or patient, their expectations are based on experiences in the consumer world. Desirability is that critical part of the experience equation that turns a user experience from one that gets the job done yet diminishes the spirit, to one that makes patients truly feel better. Medical device companies that understand these lessons and embrace the entire user experience will become market leaders as they connect with users in powerful ways.

Session Title:
FDA Expectations Demand HFE and ID Collaboration
MICHAEL WIKLUND and SARA WAXBERG

Medical technology advancements and FDA's raised expectations regarding medical device use-safety is compelling human factors engineering (HFE) and industrial design (ID) professionals to integrate their user interface development efforts more than ever before. This session will begin with an overview of the importance of engineering both use-safety and usability into medical devices, followed by an overview of the regulatory landscape influencing user interface design. A panel discussion will ensure, focusing on the ways that ID and HF specialists can collaborate to achieve the common goal of producing safe and usable medical devices that also hold appeal.

Session Title:
Fight Not Flight: Creating Stress Resistant Experiences
NASAHN SHEPPARD and KEVIN LOZEAU

Assuring usability for anything we create can be difficult. But it’s especially challenging in the field of medical products and services when a person under stress must carry out critical tasks. Design teams need to optimize usability under worst-case and often unpredictable circumstances. In this workshop, participants will work with each other to explore the implications of intuition, instinct, preconception and instructions on usability. Focusing on designing for people, Lozeau and Sheppard will discuss the motivations of patients, nurses and doctors in the context of both physical and cognitive human abilities.

Key workshop discussion points:

  • Considering the impact of instinct, preconception and physical cues when designing for extreme usability.
  • How can design uncover and accommodate the drivers of user actions or behaviors to reduce stress?
  • The importance of observational techniques and data collection when identifying design actionable insights.

Breakout Title:
Getting to a More Sustainable Future for Health Care—from the Product to the System
ROBERT MEURER and BILL EVANS

The health-care community is interested in being more sustainable, but often stakeholders in medical companies resist change and lack vision. As a design profession, we need to address this frame of mind and meet this constituency on their own ground. This session will put forward ideas and actions that have worked, both within corporations (Meurer with GE Healthcare) and for consultants (Evans at Bridge Design). With the Affordable Care Act and the device tax on the horizon, cost is a big concern, but companies can reduce their footprint without pressing the reset button on design or increasing product costs. Design-led initiatives will be presented that can significantly improve both sustainability and the patient experience of the future health-care system.

Breakout Title:
Health Care. Fit for Human Use?
AIDAN PETRIE

Health care is in need of designers. There is a steady rise in the understanding and value of designers in the health-care field. Designers are being engaged to define and implement the changes that are gravely needed within the health-care system, but they must learn the workings of the industry. Using many of the traditional tools (and a few new ones), designers can facilitate research, lead co-creation, visualize change and implement plans that make products and systems safer and more satisfactory to use. In this talk, we will present a variety of case studies from programs that have been managed and executed by designers working in the health-care system, interfacing with the regulators directly and helping develop the future of medical technology. A critical role for designers at the core interface between man and machine, or system and user is gradually emerging and with it an opportunity to improve health care.

Breakout Title:
Making Design Research Actionable for Health-Care Products
ERIC SCHMID and CYNTHIA KOSSAYAN

As companies attempt to develop devices that add value to users’ lives, they rely on research to connect with customers and understand human behavior and motivation. Unfortunately, many organizations still struggle to transform design research data into actionable product innovation. There’s a gap between where information gathering leaves off and design begins. This presentation will show how successfully blending design and research perspectives helps a team look at problems holistically and develop unexpected solutions. Speakers will identify points of disconnect between researchers and designers and introduce a set of visual information design tools for bridging the gap. You will learn three key strategies for making research actionable—creating a framework, making information visual and creating an empathetic experience. Additionally, you will see them applied in successful collaborations that use the perspectives of designers and researchers to develop medical products that create positive experiences for their users.

Session Title:
Medical Device Design: Lipstick on a Pig or a Concerto for Industrial Design?
MARY BETH PRIVITERA, IDSA with SEAN HÄGEN, IDSA, ALEX THERRIEN, SCOTT STROPKAY, IDSA and TOR ALDEN, IDSA

Industrial designers have traditionally been good at bridging between the objective and subjective, quantitative and qualitative, marketing and engineering. Considering the priority of safety and efficacy in the medical design process, the role of ID as the bridge between clinical, marketing, human factors, engineering and regulatory has become increasingly challenging. Throughout the design process each of these main content areas must ultimately act in concert.

A panel of medical device design experts will discuss the following issues:

  • Due to regulatory requirements, has ID become too focused on ergonomics and design research? What is the positive and negative impact on ID?
  • What is the optimal engagement timing of industrial design in the standardized development process? Why?
  • Considering the priority of the user experience, how does product semantics play a role?
  • What is the impact on design when the POC changes while clinical utility and technical challenges remain constant?

in
Submitted by askkurthow on May 11, 2012 - 11:58am